Johnson & Johnson (JNJ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Johnson & Johnson | JNJ | Healthcare | Drug Manufacturers - General | 94 | 10.0% |
| Current Price (10/04) | $165.62 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 95,588.0 | |||
| Sales Growth Forecast | 4.4% | |||
| Net Profit Margin | 28.2% | |||
| Projected Shares Outstanding | 2,508.00 | |||
| EPS - Five year Forecast | $13.30 | |||
| Average P/E Ratio | 18.0 | |||
| Projected Average Price | $239.41 | |||
| Price Appreciation (Annualized) | 7.6% | |||
| Annual Dividend Yield | 2.4% | |||
| Projected Annual Return | 10.0% | |||
| Quality | ||||
| Financial Strength | 100 | 25.0 | ||
| EPS Stability | 92 | 22.9 | ||
| Industry Sales Growth Rate | 4.0% | 13.6 | ||
| Industry Net Profit Margin | 26.5% | 13.3 | ||
| Calculated Quality Rating | 74.8 | |||
| Fool CAPS | ||||
Total Players
13609
Outperforms
514
Underperforms
All-Stars (2764)
2707
Outperforms (98%)
57
Underperforms
|
||||
| Fundamental Data Updated: 08/12/2022 | ||||